271 related articles for article (PubMed ID: 8232765)
1. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
Diamant M; de Wied D
Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
[TBL] [Abstract][Full Text] [Related]
2. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
Diamant M; de Wied D
Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
Diamant M; Kashtanov SI; Fodor M; de Wied D
Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
[TBL] [Abstract][Full Text] [Related]
4. The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats.
Diamant M; Croiset G; de Wied D
Peptides; 1992; 13(6):1149-58. PubMed ID: 1494497
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha helical CRF 9-41 on neurophysiological and autonomic patterns induced by CRF in the rabbit.
Marchioni E; Maurelli M; Tartara A
Boll Soc Ital Biol Sper; 1993 Apr; 69(4):265-72. PubMed ID: 8129907
[TBL] [Abstract][Full Text] [Related]
6. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
Saunders WS; Thornhill JA
Peptides; 1986; 7(4):597-601. PubMed ID: 3020526
[TBL] [Abstract][Full Text] [Related]
7. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
9. The neuropeptide CRF is involved in the modulation of the baroreflex during hindlimb ischaemia in the anaesthetized rat.
Turnbull AV; Kirkman E; Rothwell NJ; Little RA
J Physiol; 1993 Aug; 468():529-41. PubMed ID: 8254521
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
Pelleymounter MA; Joppa M; Ling N; Foster AC
J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role.
Cador M; Ahmed SH; Koob GF; Le Moal M; Stinus L
Brain Res; 1992 Dec; 597(2):304-9. PubMed ID: 1473001
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, alpha-helical CRF9-41; comparison with effect on ACTH release.
Corder R; Turnill D; Ling N; Gaillard RC
Peptides; 1992; 13(1):1-6. PubMed ID: 1320258
[TBL] [Abstract][Full Text] [Related]
14. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
Martínez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
15. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.
Kumar KB; Karanth KS
J Neural Transm (Vienna); 1996; 103(8-9):1117-26. PubMed ID: 9013399
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
17. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
18. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
Korte SM; Korte-Bouws GA; Bohus B; Koob GF
Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
[TBL] [Abstract][Full Text] [Related]
19. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
Martínez V; Rivier J; Taché Y
J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
[TBL] [Abstract][Full Text] [Related]
20. Differential behavioral actions of corticotropin-releasing factor (CRF).
Veldhuis HD; De Wied D
Pharmacol Biochem Behav; 1984 Nov; 21(5):707-13. PubMed ID: 6334857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
